Department of Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands.
NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands.
J Cachexia Sarcopenia Muscle. 2021 Aug;12(4):983-992. doi: 10.1002/jcsm.12723. Epub 2021 Jun 1.
Myosteatosis has been associated with shorter overall survival in cancer patients. The increase in ectopic fat might not be limited to skeletal muscle only and might also extend to other sites such as the liver, resulting in non-alcoholic fatty liver disease (NAFLD). In this study, we assessed the relationship between myosteatosis and NAFLD and their association with overall survival in patients with colorectal liver metastases undergoing partial hepatectomy.
Patients were selected from a prospective cohort of 289 consecutive patients with colorectal liver metastases. All patients with a preoperative computed tomography (CT)-scan and liver biopsy obtained during surgery were included. If available a second pre-operative CT scan was used to calculate changes in body composition over time. Muscle radiation attenuation was defined as the average Hounsfield units on CT of all muscle tissue at the L3 level. Liver biopsies were graded by a liver pathologist using the steatosis, activity, and fibrosis scoring system for NAFLD.
Two-hundred and eighteen patients had an available liver biopsy of which 131 patients had two available pre-operative CT scans with an average time interval of 3.2 months. One-hundred and thirty-five (62%) biopsies were classified as NAFLD. In multivariable Cox-regression analysis, NAFLD [hazard ratio (HR): 1.8, 95%-confidence interval (CI) 1.0-3.0, P = 0.037], increase in myosteatosis (HR 1.8, 95%-CI 1.1-2.9, P = 0.018), and skeletal muscle loss (HR 1.7, 95%-CI 1.0-2.9, P = 0.035) were independently associated with shorter overall survival while high visceral adipose tissue fat content was associated with longer overall survival (HR: 0.7, 95%-CI 0.5-0.9, P = 0.014).
Ectopic fat content of liver as well as skeletal muscle tissue is independently associated with shorter overall survival in patients with colorectal liver metastases, while increased visceral adipose tissue fat content is associated with longer overall survival.
脂肪浸润与癌症患者的总生存时间缩短有关。异位脂肪的增加可能不仅局限于骨骼肌,还可能延伸到其他部位,如肝脏,导致非酒精性脂肪性肝病(NAFLD)。在这项研究中,我们评估了肌内脂肪浸润与 NAFLD 之间的关系及其与接受部分肝切除术的结直肠癌肝转移患者总生存时间的关系。
本研究从 289 例连续的结直肠癌肝转移患者的前瞻性队列中选择患者。所有患者均行术前 CT 扫描,并在手术期间获得肝活检。如果可行,使用第二次术前 CT 扫描来计算随时间推移的身体成分变化。肌肉辐射衰减定义为 L3 水平所有肌肉组织的平均 CT 亨斯菲尔德单位数。肝活检由肝病理学家使用非酒精性脂肪性肝病的脂肪变性、活动度和纤维化评分系统进行分级。
218 例患者有可用的肝活检,其中 131 例患者有两次平均间隔 3.2 个月的术前 CT 扫描。135 例(62%)活检被归类为非酒精性脂肪性肝病。多变量 Cox 回归分析显示,非酒精性脂肪性肝病[风险比(HR):1.8,95%可信区间(CI)1.0-3.0,P=0.037]、肌内脂肪浸润增加(HR 1.8,95%CI 1.1-2.9,P=0.018)和骨骼肌丢失(HR 1.7,95%CI 1.0-2.9,P=0.035)与总生存时间缩短独立相关,而高内脏脂肪组织脂肪含量与总生存时间延长相关(HR:0.7,95%CI 0.5-0.9,P=0.014)。
结直肠癌肝转移患者肝脏和骨骼肌组织的异位脂肪含量与总生存时间缩短独立相关,而内脏脂肪组织脂肪含量增加与总生存时间延长相关。